Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Star
1724.7000 -35.90 (-2.04%)
NSE Aug 21, 2026 15:31 PM
Volume: 274.8K
High vol. this week

logo
Rubicon Research Ltd.
13 Nov 2025
1724.70
-2.04%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Motilal Oswal increased Buy price target of Rubicon Research Ltd. to 1915.0 on 15 Aug, 2026.
More from Rubicon Research Ltd.
Recommended
Five Interesting Stocks Today - August 21, 2026
The Baseline | 21 Aug 2026
Market closes flat as investors turn cautious after Trump’s Iran sanctions announcement
Trendlyne Marketwatch | 21 Aug 2026
India’s IPO market: From listing gains to long-term performance
The Baseline | 20 Aug 2026